Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Magle Chemoswed Holding AB (publ) initiates a written procedure in order to utilise the option to pay PIK Interest under its super senior secured fixed rate bonds

Magle ChemoswedPress release17.11.2026, 13.55

Magle Chemoswed Holding AB (publ) (the "Company") hereby announces that it, through Nordic Trustee & Agency AB (publ) as agent (the “Agent”) under its super senior secured fixed rate bonds with ISIN NO0013758086 (the "Bonds"), has initiated a written procedure (the "Written Procedure") in order to enable Bondholders to vote for or against the Company's request to utilise the PIK Component for the current Interest Period which ends on 1 December 2026 (with Interest Payment Date occurring on 2 December 2026).

Pursuant to the Terms and Conditions of the Bonds, the Company may elect to pay a part of the Interest under the Bonds as PIK Interest, subject to the Company giving prior notice of no less than 10 CSD Business Days' before the first day of the relevant Interest Period. For the current Interest Period the deadline for serving a notice to elect PIK Interest expired before the issuance of the Bonds and it was therefore not technically possible for the Company to elect the option to pay PIK Interest for the current Interest Period. It is against this background that the Company has initiated the Written Procedure.

 

Voting Information
 
To be eligible to participate in the Written Procedure, a person must be a holder of Bonds on 19 November 2026, meaning that the person must be registered on a securities account with Verdipapirsentralen ASA (Euronext Securities Oslo) as a direct registered owner or authorised nominee with respect to one or several Bonds.
 
The Agent must receive the voting form no later than 14:00 CET on 2 December 2026 either by mail, courier or email to the Agent using the contact details set out in Section 4.6 in the notice of the Written Procedure. Votes received thereafter may be disregarded.
 
For further information regarding the Written Procedure and the requests, including the full details of the proposal, please refer to the notice of Written Procedure available on the Company's website (https://maglegroup.com/) and via the Agent's information service Stamdata (https://stamdata.com/).

Contacts


Aaron Wong, CEO, phone +46 (0)76 664 35 79, aaron.wong@maglegroup.com

About Us


The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. Today, the Group includes two operational areas. Magle Chemoswed – a contract manufacturing organization (CMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle Biopolymers A/S - a specialized manufacturing organization of Dextran technology. Learn more on www.maglechemoswed.com and www.maglegroup.com and www.maglebiopolymers.com

Attachments


Magle Chemoswed Holding AB (publ) initiates a written procedure in order to utilise the option to pay PIK Interest under its super senior secured fixed rate bonds